Preoperative Proteinuria Predicts Adverse Renal Outcomes after Coronary Artery Bypass Grafting
Generics for other agents are expected sometime after 2027
Finally, the importance of data transparency and reproducibility cannot be overstated
Prescription semaglutide and tirzepatide products carry medication-specific warnings, precautions, contraindications, interactions, and potential adverse effects beyond what's listed on a brand FAQ
Those with a history of weight cycling, losing and regaining significant amounts repeatedly, often benefit from continued medication support
Wegovy (semaglutide) prescribing information, Food and Drug Administration (2024) Insulin resistance & prediabetes, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2025) Efficacy and safety of once-weekly semaglutide 2.4 mg versus placebo in people with obesity and prediabetes (STEP 10): A randomised, double-blind, placebo-controlled, multicentre phase 3 trial, The Lancet Diabetes & Endocrinology (2024) FDA approves first treatment to reduce risk of serious heart problems specifically in adults with obesity or overweight, Food and Drug Administration (2024) What is the list price for Wegovy and will it impact me?, NovoCare Details about the program, Centers for Disease Control and Prevention (2024) Medicare Diabetes Prevention Program, Centers for Medicare and Medicaid Services Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
